24 HR canagliflozin 50 MG / metformin hydrochloride 500 MG Extended Release Oral Tablet
RxNorm concept 1811010, clinical drug (scd). Prescribable name: canagliflozin 50 MG / metFORMIN HCl 500 MG 24HR Extended Release Oral Tablet.
- RxCUI
- 1811010
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1811010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
24 HR canagliflozin 50 MG / metFORMIN hydrochloride 500 MG Extended Release Oral Tablet; canagliflozin 50 MG / metFORMIN hydrochloride 500 MG 24HR Extended Release Oral Tablet; canagliflozin 50 MG / metformin hydrochloride 500 MG 24HR Extended Release Oral Tablet
Related concepts
- metformin hydrochloride 500 MG (SCDC, consists of)
- canagliflozin 50 MG (SCDC, consists of)
- Extended Release Oral Tablet (DF, has dose form)
- 24 HR canagliflozin 50 MG / metformin hydrochloride 500 MG Extended Release Oral Tablet [Invokamet] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1811010 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1811010 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1811010. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.